1. Lifeward will release Q2 2025 financial results on August 14. 2. CEO Mark Grant will lead the earnings call at 8:30 a.m. EDT. 3. Lifeward focuses on innovative medical technologies for physical rehabilitation. 4. The company’s portfolio includes several cutting-edge rehabilitation products. 5. Lifeward operates in the U.S., Israel, and Germany, expanding its global reach.
The upcoming earnings report may indicate strong growth, similar to past quarters where advancements in rehabilitation technologies positively shifted market perception.
The earnings report can provide key indicators of company health, impacting investor sentiment and stock performance.
Earnings reports typically influence stock prices immediately, as investors react quickly to financial results.
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that the Company will release its second quarter 2025 financial results before the markets open on Thursday, August 14, 2025.
Mark Grant, President and Chief Executive Officer, and Almog Adar, Vice President of Finance, will host a conference call and live webcast at 8:30 a.m. EDT to discuss the financial results. To access the call, analysts and investors may utilize the following:
| Toll free (U.S.) | 1-833-316-0561 |
| International (U.S) | 1-412-317-0690 |
| Germany | 0800-6647650 |
| Israel | 1-80-9212373 |
| Access Code | Please reference the "Lifeward Earnings Call" |
The conference call will be webcast live and the webcast can be accessed through a link on the Company's website at GoLifeward.com in the "Investors" section, or through the following link: https://edge.media-server.com/mmc/p/kegov6it/. An archived webcast will also be available on the company's website.
About Lifeward
Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the MyoCycle FES System, and the ReStore Exo-Suit.
Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward mission and product portfolio, please visit GoLifeward.com.
Lifeward®, ReWalk®, ReStore® and Alter G® are registered trademarks of Lifeward Ltd. and/or its affiliates.
Lifeward Media Relations:
Kathleen O'Donnell
Vice President, Marketing & New Business Development
Lifeward Ltd.
E: media@golifeward.com
Lifeward Investor Contact:
Almog Adar
Vice President of Finance
Lifeward Ltd.
E: ir@golifeward.com
